Comparison of Midazolam or Dexmedetomidine on Epileptiform EEG During Sevoflurane Mask Induction
Primary Purpose
Inhalation Anesthesia
Status
Unknown status
Phase
Phase 4
Locations
China
Study Type
Interventional
Intervention
Placebos
Midazolam
Dexmedetomidine
Sponsored by
About this trial
This is an interventional prevention trial for Inhalation Anesthesia focused on measuring sevoflurane, epileptiform EEG, midazolam, dexmedetomidine
Eligibility Criteria
Inclusion Criteria:
- ASA physical status 1-2
- Scheduled for general anesthesia
Exclusion Criteria:
- Patients with a history of neurological, mental illnes
- Patients with a history of congenital heart disease
- Patients with a history of allergies to related drugs
Sites / Locations
- Shanghai Ninth People's Hospital,Affililated to Shanghai Jiaotong University School of Medicine
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Placebo Comparator
Experimental
Experimental
Arm Label
Group A
Group B
Group C
Arm Description
Outcomes
Primary Outcome Measures
incidence of epileptiform EEG
EEG were visually analyzed off-line by a neurophysiologist familiar with anesthesia EEG and blinded to the randomization. EEG abnormalities related to epileptic features were classified according to the description of Vakkuri and Jaaskelainen, and the recommendations of Constant: spikes and spikes with slow wave complexes (SW), rhythmic polyspikes corresponding to waveforms appearing at regular intervals (RPS) and periodic epileptiform discharge (PED), which refers to periodic hypersynchronized complexes occurring bilaterally. These entire electroencephalographic phenomena were considered as epileptiform EEG if their duration was longer than three seconds.
Secondary Outcome Measures
electroencephalographic changes
the delay between the start of induction and the first changes in electroencephalographic activity (appearance of β, θ, or δ rhythms)
electroencephalographic changes
the occurrence of burst suppressions
electroencephalographic changes
duration of suppression period, i.e. the sum of the EEG silences.
hemodynamic changes
blood pressure
hemodynamic changes
heart rate
hemodynamic changes
blood pressure
hemodynamic changes
heart rate
hemodynamic changes
blood pressure
hemodynamic changes
heart rate
hemodynamic changes
blood pressure
hemodynamic changes
heart rate
hemodynamic changes
blood pressure
hemodynamic changes
heart rate
hemodynamic changes
blood pressure
hemodynamic changes
heart rate
hemodynamic changes
blood pressure
hemodynamic changes
heart rate
intubation time
from taking of the intubation device to successful intubation
Full Information
NCT ID
NCT03394430
First Posted
December 17, 2017
Last Updated
September 23, 2018
Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
1. Study Identification
Unique Protocol Identification Number
NCT03394430
Brief Title
Comparison of Midazolam or Dexmedetomidine on Epileptiform EEG During Sevoflurane Mask Induction
Official Title
Comparison of Intranasal Midazolam or Dexmedetomidine on Epileptiform EEG During Sevoflurane Mask Induction in Children
Study Type
Interventional
2. Study Status
Record Verification Date
February 2018
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2018 (Anticipated)
Primary Completion Date
December 31, 2018 (Anticipated)
Study Completion Date
February 1, 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
Induction with high sevoflurane concentrations may trigger epileptiform electroencephalographic activity without motor or cardiovascular manifestations in healthy patients. No other symptoms were associated in this series, and only electroencephalographic monitoring allowed the diagnosis. Midazolam and dexmedetomidine are sedatives commonly used in children before surgery. Although the mechanisms are different, both have been reported in antiepileptic effects.
This study was designed to compare the effects between intranasal midazolam or dexmedetomidine on epileptiform EEG during sevoflurane mask induction in children. Anaesthesia was induced with 8% sevoflurane. The patients were randomly assigned to Group A (n=15, preoperative intranasal normal saline), Group B (n=15, preoperative intranasal 0.25mg/kg midazolam), and Group C (n=15, preoperative intranasal 1μg/kg dexmedetomidine). An electroencephalogram was recorded before and during induction up to 10 min after the start of induction.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inhalation Anesthesia
Keywords
sevoflurane, epileptiform EEG, midazolam, dexmedetomidine
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
45 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group A
Arm Type
Placebo Comparator
Arm Title
Group B
Arm Type
Experimental
Arm Title
Group C
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Placebos
Intervention Description
Patients in Group A receive intranasal normal saline before anesthesia. Anaesthesia was induced with 8% sevoflurane initially. Sevoflurane concentration decreased to 2% after intubation. An electroencephalogram was recorded before and during induction up to 10 min after the start of induction.
Intervention Type
Drug
Intervention Name(s)
Midazolam
Intervention Description
Patients in Group B receive intranasal 0.25mg/kg midazolam before anesthesia. Anaesthesia was induced with 8% sevoflurane initially. Sevoflurane concentration decreased to 2% after intubation. An electroencephalogram was recorded before and during induction up to 10 min after the start of induction.
Intervention Type
Drug
Intervention Name(s)
Dexmedetomidine
Intervention Description
Patients in Group C receive intranasal 1μg/kg dexmedetomidine before anesthesia. Anaesthesia was induced with 8% sevoflurane initially. Sevoflurane concentration decreased to 2% after intubation. An electroencephalogram was recorded before and during induction up to 10 min after the start of induction.
Primary Outcome Measure Information:
Title
incidence of epileptiform EEG
Description
EEG were visually analyzed off-line by a neurophysiologist familiar with anesthesia EEG and blinded to the randomization. EEG abnormalities related to epileptic features were classified according to the description of Vakkuri and Jaaskelainen, and the recommendations of Constant: spikes and spikes with slow wave complexes (SW), rhythmic polyspikes corresponding to waveforms appearing at regular intervals (RPS) and periodic epileptiform discharge (PED), which refers to periodic hypersynchronized complexes occurring bilaterally. These entire electroencephalographic phenomena were considered as epileptiform EEG if their duration was longer than three seconds.
Time Frame
0 min after induction, up to 10 min
Secondary Outcome Measure Information:
Title
electroencephalographic changes
Description
the delay between the start of induction and the first changes in electroencephalographic activity (appearance of β, θ, or δ rhythms)
Time Frame
0 min after induction, up to 10 min
Title
electroencephalographic changes
Description
the occurrence of burst suppressions
Time Frame
0 min after induction, up to 10 min
Title
electroencephalographic changes
Description
duration of suppression period, i.e. the sum of the EEG silences.
Time Frame
0 min after induction, up to 10 min
Title
hemodynamic changes
Description
blood pressure
Time Frame
1 min before induction
Title
hemodynamic changes
Description
heart rate
Time Frame
1 min before induction
Title
hemodynamic changes
Description
blood pressure
Time Frame
during induction procedure
Title
hemodynamic changes
Description
heart rate
Time Frame
during induction procedure
Title
hemodynamic changes
Description
blood pressure
Time Frame
2 min after induciton
Title
hemodynamic changes
Description
heart rate
Time Frame
2 min after induciton
Title
hemodynamic changes
Description
blood pressure
Time Frame
4 min after induciton
Title
hemodynamic changes
Description
heart rate
Time Frame
4 min after induciton
Title
hemodynamic changes
Description
blood pressure
Time Frame
6 min after induciton
Title
hemodynamic changes
Description
heart rate
Time Frame
6 min after induciton
Title
hemodynamic changes
Description
blood pressure
Time Frame
8 min after induciton
Title
hemodynamic changes
Description
heart rate
Time Frame
8 min after induciton
Title
hemodynamic changes
Description
blood pressure
Time Frame
10 min after induciton
Title
hemodynamic changes
Description
heart rate
Time Frame
10 min after induciton
Title
intubation time
Description
from taking of the intubation device to successful intubation
Time Frame
0 min after intubation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
ASA physical status 1-2
Scheduled for general anesthesia
Exclusion Criteria:
Patients with a history of neurological, mental illnes
Patients with a history of congenital heart disease
Patients with a history of allergies to related drugs
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yu Sun, MD,PhD
Phone
0086-136-1189-5542
Email
dr_sunyu@163.com
First Name & Middle Initial & Last Name or Official Title & Degree
Chenyu Jin
Email
jinchenyu8@163.com
Facility Information:
Facility Name
Shanghai Ninth People's Hospital,Affililated to Shanghai Jiaotong University School of Medicine
City
Shanghai
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yu Sun, MD,PhD
Phone
0086-136-1189-5542
Email
dr_sunyu@163.com
First Name & Middle Initial & Last Name & Degree
Chenyu Jin
12. IPD Sharing Statement
Learn more about this trial
Comparison of Midazolam or Dexmedetomidine on Epileptiform EEG During Sevoflurane Mask Induction
We'll reach out to this number within 24 hrs